232 related articles for article (PubMed ID: 36685582)
1. Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19.
Hopkins FR; Govender M; Svanberg C; Nordgren J; Waller H; Nilsdotter-Augustinsson Å; Henningsson AJ; Hagbom M; Sjöwall J; Nyström S; Larsson M
Front Immunol; 2022; 13():1082912. PubMed ID: 36685582
[TBL] [Abstract][Full Text] [Related]
2. Single-cell immune profiling reveals long-term changes in myeloid cells and identifies a novel subset of CD9
Pandori WJ; Padgett LE; Alimadadi A; Gutierrez NA; Araujo DJ; Huh CJ; Olingy CE; Dinh HQ; Wu R; Vijayanand P; Chee SJ; Ottensmeier CH; Hedrick CC
J Leukoc Biol; 2022 Nov; 112(5):1053-1063. PubMed ID: 35866369
[TBL] [Abstract][Full Text] [Related]
3. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
Front Immunol; 2021; 12():691725. PubMed ID: 34248984
[TBL] [Abstract][Full Text] [Related]
4. Impaired function and delayed regeneration of dendritic cells in COVID-19.
Winheim E; Rinke L; Lutz K; Reischer A; Leutbecher A; Wolfram L; Rausch L; Kranich J; Wratil PR; Huber JE; Baumjohann D; Rothenfusser S; Schubert B; Hilgendorff A; Hellmuth JC; Scherer C; Muenchhoff M; von Bergwelt-Baildon M; Stark K; Straub T; Brocker T; Keppler OT; Subklewe M; Krug AB
PLoS Pathog; 2021 Oct; 17(10):e1009742. PubMed ID: 34614036
[TBL] [Abstract][Full Text] [Related]
5. Distinct and dynamic activation profiles of circulating dendritic cells and monocytes in mild COVID-19 and after yellow fever vaccination.
Winheim E; Eser T; Deák F; Ahmed MIM; Baranov O; Rinke L; Eisenächer K; Santos-Peral A; Karimzadeh H; Pritsch M; Scherer C; Muenchhoff M; Hellmuth JC; von Bergwelt-Baildon M; Olbrich L; Hoelscher M; Wieser A; Kroidl I; Rothenfusser S; Geldmacher C; Krug AB
Eur J Immunol; 2023 Mar; 53(3):e2250090. PubMed ID: 36404054
[TBL] [Abstract][Full Text] [Related]
6. Respiratory and systemic monocytes, dendritic cells, and myeloid-derived suppressor cells in COVID-19: Implications for disease severity.
Falck-Jones S; Österberg B; Smed-Sörensen A
J Intern Med; 2023 Feb; 293(2):130-143. PubMed ID: 35996885
[TBL] [Abstract][Full Text] [Related]
7. Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals.
Park J; Dean LS; Jiyarom B; Gangcuangco LM; Shah P; Awamura T; Ching LL; Nerurkar VR; Chow DC; Igno F; Shikuma CM; Devendra G
Front Immunol; 2023; 14():1151780. PubMed ID: 37077911
[TBL] [Abstract][Full Text] [Related]
8. CCR2 Signaling Restricts SARS-CoV-2 Infection.
Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
[TBL] [Abstract][Full Text] [Related]
9. Human influenza virus infection elicits distinct patterns of monocyte and dendritic cell mobilization in blood and the nasopharynx.
Vangeti S; Falck-Jones S; Yu M; Österberg B; Liu S; Asghar M; Sondén K; Paterson C; Whitley P; Albert J; Johansson N; Färnert A; Smed-Sörensen A
Elife; 2023 Feb; 12():. PubMed ID: 36752598
[TBL] [Abstract][Full Text] [Related]
10. Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection.
Albayrak N; Orte Cano C; Karimi S; Dogahe D; Van Praet A; Godefroid A; Del Marmol V; Grimaldi D; Bondue B; Van Vooren JP; Mascart F; Corbière V
Front Immunol; 2022; 13():769839. PubMed ID: 35422799
[TBL] [Abstract][Full Text] [Related]
11. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.
Zingaropoli MA; Nijhawan P; Carraro A; Pasculli P; Zuccalà P; Perri V; Marocco R; Kertusha B; Siccardi G; Del Borgo C; Curtolo A; Ajassa C; Iannetta M; Ciardi MR; Mastroianni CM; Lichtner M
Front Immunol; 2021; 12():627548. PubMed ID: 33777012
[TBL] [Abstract][Full Text] [Related]
12. Intermediate Monocytes with PD-L1 and CD62L Expression as a Possible Player in Active SARS-CoV-2 Infection.
Rutkowska E; Kwiecień I; Kłos K; Rzepecki P; Chciałowski A
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458548
[TBL] [Abstract][Full Text] [Related]
13. Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity.
Kvedaraite E; Hertwig L; Sinha I; Ponzetta A; Hed Myrberg I; Lourda M; Dzidic M; Akber M; Klingström J; Folkesson E; Muvva JR; Chen P; Gredmark-Russ S; Brighenti S; Norrby-Teglund A; Eriksson LI; Rooyackers O; Aleman S; Strålin K; Ljunggren HG; Ginhoux F; Björkström NK; Henter JI; Svensson M;
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33479167
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.
Matic S; Popovic S; Djurdjevic P; Todorovic D; Djordjevic N; Mijailovic Z; Sazdanovic P; Milovanovic D; Ruzic Zecevic D; Petrovic M; Sazdanovic M; Zornic N; Vukicevic V; Petrovic I; Matic S; Karic Vukicevic M; Baskic D
PLoS One; 2020; 15(12):e0241097. PubMed ID: 33382687
[TBL] [Abstract][Full Text] [Related]
15. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
Front Immunol; 2021; 12():746021. PubMed ID: 35082777
[TBL] [Abstract][Full Text] [Related]
16. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
Boumaza A; Gay L; Mezouar S; Bestion E; Diallo AB; Michel M; Desnues B; Raoult D; La Scola B; Halfon P; Vitte J; Olive D; Mege JL
J Infect Dis; 2021 Aug; 224(3):395-406. PubMed ID: 33493287
[TBL] [Abstract][Full Text] [Related]
17. Reduced monocyte proportions and responsiveness in convalescent COVID-19 patients.
Ravkov EV; Williams ESCP; Elgort M; Barker AP; Planelles V; Spivak AM; Delgado JC; Lin L; Hanley TM
Front Immunol; 2023; 14():1329026. PubMed ID: 38250080
[TBL] [Abstract][Full Text] [Related]
18. The S1 Subunit of the SARS-CoV-2 Spike Protein Activates Human Monocytes to Produce Cytokines Linked to COVID-19: Relevance to Galectin-3.
Schroeder JT; Bieneman AP
Front Immunol; 2022; 13():831763. PubMed ID: 35392091
[TBL] [Abstract][Full Text] [Related]
19. Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery.
Ruenjaiman V; Sodsai P; Kueanjinda P; Bunrasmee W; Klinchanhom S; Reantragoon R; Tunvirachaisakul C; Manothummetha K; Mejun N; Liengswangwong K; Torvorapanit P; Paitoonpong L; Putcharoen O; Palaga T; Hirankarn N;
J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):993-1004. PubMed ID: 36220753
[TBL] [Abstract][Full Text] [Related]
20. Recovery of systemic hyperinflammation in patients with severe SARS-CoV-2 infection.
Langnau C; Janing H; Kocaman H; Gekeler S; Günter M; Petersen-Uribe Á; Jaeger P; Koch B; Kreisselmeier KP; Castor T; Rath D; Gawaz MP; Autenrieth SE; Mueller KAL
Biomarkers; 2023 Feb; 28(1):97-110. PubMed ID: 36377411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
